PET imaging during radiotherapy of head and neck cancer.

Abstract

The worldwide incidence of head and neck cancer is estimated at approximately 643,000 (1). In the United States, approximately 53,640 new head and neck cancers will be diagnosed in 2013, with 11,520 deaths expected (2). The treatment choice for head and neck cancer depends on the primary site and surgical resectability; however, with an increasing effort of preservation of organ function the use of definitive radiation therapy alone or in combination with chemotherapy has been increasing, particularly in oropharyngeal cancers. PET/CT with 18F-FDG has an established role in initial staging and after completion of radiotherapy to evaluate for the need for salvage surgery. According to guidelines of the National Comprehensive Cancer Network (NCCN), salvage surgery is not necessary

DOI: 10.2967/jnumed.112.114561

Cite this paper

@article{Menda2013PETID, title={PET imaging during radiotherapy of head and neck cancer.}, author={Yusuf Menda and John M. Buatti}, journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine}, year={2013}, volume={54 4}, pages={497-8} }